Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
45.11
Oct 23 • 3:59 PM ET Dollar change-0.42 Percentage change(-0.92%)
Aftermarket Close
45.11
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
583.01M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Employees
-
IPO
Mar 29, 2005
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
20.05%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
2.17%
SMA50
0.85%
SMA200
7.49%
Trades
Shs Outstand
12.92M
Shs Float
12.92M
52W High
46.42 -2.83%
52W Low
37.51 20.26%
Volatility
1.76% 1.64%
ATR (14)
0.73
RSI (14)
55.95
Beta
0.61
Rel Volume
0.94
Avg Volume
42.46K
Volume
39,999
Perf Week
2.50%
Perf Month
0.29%
Perf Quarter
4.57%
Perf Half Y
15.31%
Perf YTD
9.68%
Perf Year
18.27%
Perf 3Y
22.65%
Perf 5Y
-5.05%
Perf 10Y
36.18%
Recom
-
Target Price
-
Prev Close
45.53
Price
45.11
Change %
-0.92%
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Chief Compliance Officer and Anti-Money Laundering OfficerMr. Charles Choon Sik Park
Portfolio ManagerMr. Thomas P. Callan C.F.A.
Portfolio ManagerMr. Kyle G. McClements C.F.A.
Portfolio ManagerDr. Erin Xie Ph.D.
Portfolio ManagerDr. Xiang Liu Ph.D.